Polypectomy, Endoscopic Mucosal Resection, and Endoscopic Submucosal Dissection in the Cirrhotic Population. [Review]
Citation: Clinics in Liver Disease. 26(1):13-19, 2022 02.PMID: 34802659Institution: MedStar Washington Hospital CenterDepartment: Gastroenterology/HepatologyForm of publication: Journal ArticleMedline article type(s): Journal Article | ReviewSubject headings: *Endoscopic Mucosal Resection | Dissection | Humans | Liver Cirrhosis | Treatment OutcomeYear: 2022Local holdings: Available online from MWHC library: May 1997 - presentISSN:- 1089-3261
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | 34802659 | Available | 34802659 |
Available online from MWHC library: May 1997 - present
Endoscopic mucosal resection and dissection are advanced endoscopic procedures that have proven essential for resecting premalignant and early malignant lesions throughout the gastrointestinal tract. Over time, these procedures have proven to play a key role in avoiding more invasive surgical approaches and thus decrease overall mortality. However, the success of these procedures does come with a slightly increased risk of adverse events such as bleeding and perforation. In this article, we review the literature for reported adverse events, specifically in the cirrhotic population. This article also discusses experts' opinions on approaches taken to perform these procedures with acceptable risks. Copyright (c) 2021 Elsevier Inc. All rights reserved.
English